Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape

ABSTRACT Antigen presentation and T-cell activation are dynamic processes involving signaling molecules present in both APCs and T cells. Effective APC function and T-cell activation can be compromised by viral immune evasion strategies, including those of human immunodeficiency virus type 1 (HIV-1). In this study, we determined the effects of HIV-1 Vpr on one of the initial target of the virus, dendritic cells (DC), by investigating DC maturation, cytokine profiling, and CD8-specific T-cell stimulation function followed by a second signal. Vpr impaired the expression of CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription. Cytokine profiling indicated that the presence of Vpr inhibited production of interleukin 12 (IL-12) and upregulated IL-10, whereas IL-6 and IL-1β were unaltered. Furthermore, DC infected with HIV-1 vpr+ significantly reduced the activation of antigen-specific memory and recall cytotoxic-T-lymphocyte responses. Taken together, these results indicate that HIV-1 Vpr may in part be responsible for HIV-1 immune evasion by inhibiting the maturation of costimulatory molecules and cytokines essential for immune activation.

[1]  J. Andersson,et al.  HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. , 2004, Blood.

[2]  F. Belardelli,et al.  Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis , 2004, Journal of Virology.

[3]  M. Viora,et al.  HIV‐1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Christine Trumpfheller,et al.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  John P. Moore,et al.  Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue , 2004, The Journal of experimental medicine.

[6]  Qingsheng Li,et al.  Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Yoshiyuki Nagai,et al.  Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[8]  M. Hommel On the dynamics of T‐cell activation in lymph nodes , 2004, Immunology and cell biology.

[9]  P. Jolicoeur,et al.  The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells , 2003, Journal of Virology.

[10]  N. Teleshova,et al.  Immunodeficiency virus exploitation of dendritic cells in the early steps of infection , 2003, Journal of leukocyte biology.

[11]  Bali Pulendran,et al.  Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin , 2003, Nature.

[12]  M. Stevenson,et al.  HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection , 2003, Nature.

[13]  D. McDonald,et al.  Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.

[14]  Özlem Türeci,et al.  Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  I. Lossos,et al.  Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies , 2003, Leukemia.

[16]  A. Glazyrin,et al.  Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells , 2003, Cancer Immunology, Immunotherapy.

[17]  S. Volpi,et al.  HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection , 2002, The Journal of Immunology.

[18]  W. Greene,et al.  HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. , 2002, Virology.

[19]  J. Kim,et al.  The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. , 2002, DNA and cell biology.

[20]  R. Steinman,et al.  Exploiting dendritic cells to improve vaccine efficacy. , 2002, The Journal of clinical investigation.

[21]  M. Pope,et al.  The enigma of dendritic cell-immunodeficiency virus interplay. , 2002, Current molecular medicine.

[22]  B. Gazzard,et al.  Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection , 2002, AIDS.

[23]  Michael Loran Dustin Membrane domains and the immunological synapse: keeping T cells resting and ready. , 2002, The Journal of clinical investigation.

[24]  S. Moretti,et al.  Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses1 , 2002, The Journal of Immunology.

[25]  D. Weiner,et al.  HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. , 2001, Virology.

[26]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[27]  J. Mellors,et al.  Restoration of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Responses in CD8+ T Cells from Late-Stage Patients on Prolonged Antiretroviral Therapy by Stimulation In Vitro with HIV-1 Protein-Loaded Dendritic Cells , 2001, Journal of Virology.

[28]  Yonghong Zhu,et al.  Comparison of Cell Cycle Arrest, Transactivation, and Apoptosis Induced by the Simian Immunodeficiency Virus SIVagm and Human Immunodeficiency Virus Type 1 vpr Genes , 2001, Journal of Virology.

[29]  J. Orenstein,et al.  Low levels of productive HIV infection in Langerhans cell‐like dendritic cells differentiated in the presence of TGF‐β1 and increased viral replication with CD40 ligand‐induced maturation , 2001, European journal of immunology.

[30]  F. Sallusto,et al.  Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells , 2000, Nature Immunology.

[31]  P. Matarrese,et al.  Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells1 , 2000, The Journal of Immunology.

[32]  L. Montaner,et al.  Proinflammatory response and IL‐12 expression in HIV‐1 infection , 2000, Journal of leukocyte biology.

[33]  B. Wigdahl,et al.  Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. , 2000, Virology.

[34]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[35]  K. Kuhen,et al.  Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. , 2000, Blood.

[36]  J. Hauber,et al.  Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity , 2000, Journal of Virology.

[37]  Christopher J. Miller,et al.  Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells , 2000, Journal of Virology.

[38]  M. Lederman,et al.  Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen , 2000, AIDS.

[39]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[40]  I. Chen,et al.  Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Steinman,et al.  Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. , 1999, Science.

[42]  M. Foti,et al.  Coordinated events during bacteria-induced DC maturation. , 1999, Immunology today.

[43]  D. Baltimore,et al.  HIV's evasion of the cellular immune response , 1999, Immunological reviews.

[44]  G. Chrousos,et al.  The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor , 1999, The Journal of experimental medicine.

[45]  I. Chen,et al.  Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. , 1998, Science.

[46]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[47]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[48]  J. Banchereau,et al.  Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells , 1997, The Journal of experimental medicine.

[49]  M. Bevan,et al.  Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. , 1997, Blood.

[50]  S. Bartz,et al.  Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. , 1997, Methods.

[51]  M. Clerici,et al.  Type 1 and type 2 cytokines in HIV infection -- a possible role in apoptosis and disease progression. , 1997, Annals of medicine.

[52]  R. Steinman,et al.  Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors , 1996, The Journal of experimental medicine.

[53]  N. Saksena,et al.  Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. , 1996, Virology.

[54]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[55]  A I Spira,et al.  Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques , 1996, The Journal of experimental medicine.

[56]  O. Narayan,et al.  Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat (*) , 1995, The Journal of Biological Chemistry.

[57]  F. Sallusto,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[58]  J. Sodroski,et al.  Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.

[59]  A. Frankel,et al.  Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. , 1989, Science.

[60]  K. Khalili,et al.  Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[61]  J. Abastado,et al.  HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. , 2002, Immunity.

[62]  J. Kim,et al.  HIV-1 viral protein R compromises cellular immune function in vivo. , 2002, International immunology.

[63]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[64]  M. Bukrinsky,et al.  Viral protein R of HIV‐1 , 1999, Reviews in medical virology.

[65]  D. Ho,et al.  Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques , 1998 .

[66]  D. Green,et al.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. , 1997, Nature medicine.

[67]  A. Osterhaus,et al.  Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. , 1990, AIDS.

[68]  B. Watkins,et al.  Understanding HIV-1 infection of the brain: a challenge for neurobiologists. , 1990, AIDS.